عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

China Plans to Send More Pandas to US Zoo

A Chinese giant panda male Ru Yi eats bamboo at its enclosure at the Moscow Zoo in Moscow on February 13, 2024, as the zoo celebrates its 160th anniversary. (Photo by NATALIA KOLESNIKOVA / AFP)
A Chinese giant panda male Ru Yi eats bamboo at its enclosure at the Moscow Zoo in Moscow on February 13, 2024, as the zoo celebrates its 160th anniversary. (Photo by NATALIA KOLESNIKOVA / AFP)
TT
TT

China Plans to Send More Pandas to US Zoo

A Chinese giant panda male Ru Yi eats bamboo at its enclosure at the Moscow Zoo in Moscow on February 13, 2024, as the zoo celebrates its 160th anniversary. (Photo by NATALIA KOLESNIKOVA / AFP)
A Chinese giant panda male Ru Yi eats bamboo at its enclosure at the Moscow Zoo in Moscow on February 13, 2024, as the zoo celebrates its 160th anniversary. (Photo by NATALIA KOLESNIKOVA / AFP)

China said Thursday it had signed agreements to send pandas to a zoo in San Diego, after nearly all the beloved black-and-white animals on loan in the United States were returned during years of diplomatic tensions.

Foreign ministry spokesperson Mao Ning told a regular press briefing that "Chinese institutions have already signed agreements with... the San Diego Zoo in the US".

The agreement centered "on a new round of cooperation in giant panda protection", she said.

A deal was also signed with a zoo in Madrid, and Beijing is in talks with zoos in Washington and Vienna, she added, according to AFP.

China has long deployed the fluffy envoys to various countries as "panda diplomacy", often to further its foreign policy aims.

Tensions between Washington and Beijing mean that only a handful of the bears remain in the United States, with three having left the national zoo in Washington in November.

The last remaining pandas in the United States, currently at a zoo in the southern city of Atlanta, are due to return to China by late 2024.

But after a meeting last year with US President Joe Biden, Chinese leader Xi Jinping said that China could send new pandas as "envoys of friendship between the Chinese and American people."

The White House said it would be happy to have more of the bamboo-chewing bears.

"Giant pandas are a national treasure of China and are deeply loved by people all over the world," Mao said on Thursday.

"We look forward to a new round of international cooperation on the protection of giant pandas with the relevant countries," she said.

There are an estimated 1,860 giant pandas left in the wild, according to environmental group WWF, and about 600 in captivity in panda centers, zoos and wildlife parks worldwide.

Most Viewed

 
 
Varieties

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”